When Amazon, JPMorgan Chase, and Berkshire Hathaway in 2018 announced they would form a joint venture called Haven, it sent ripples throughout the health care industry at the thought of how those three companies could disrupt the health care space. Now, three years later, the venture has shut down, but what can health care leaders learn from the rise and fall of Haven? In this episode, Rae sits down with Advisory Board's Andrew Rebhan to discuss exactly that, among other topics like why big tech is even trying to get into the health care space in the first place.
- Was Haven just 'too big to succeed'?
- After years of hype, IBM wants to sell Watson Health. What does that mean for health AI?
- Our take: What Google's $100M investment in Amwell means for virtual care
- Weekly line: Big Tech is driving even deeper into health care amid Covid-19
- Is 'Big Retail' the next big health care disruptor?
- Around the nation: How AMA wants Big Tech to fight vaccine misinformation
For resources on what to expect under the Biden-Harris administration, visit advisory.com/BidenHarris. Stay connected with Advisory Board and our experts by following us on Facebook, LinkedIn, and Twitter.